Page last updated: 2024-11-04

risedronic acid and Auricular Fibrillation

risedronic acid has been researched along with Auricular Fibrillation in 2 studies

Risedronic Acid: A pyridine and diphosphonic acid derivative that acts as a CALCIUM CHANNEL BLOCKER and inhibits BONE RESORPTION.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Grosso, A1
Douglas, I1
Hingorani, A1
MacAllister, R1
Smeeth, L1
Karam, R1
Camm, J1
McClung, M1

Other Studies

2 other studies available for risedronic acid and Auricular Fibrillation

ArticleYear
Oral bisphosphonates and risk of atrial fibrillation and flutter in women: a self-controlled case-series safety analysis.
    PloS one, 2009, Volume: 4, Issue:3

    Topics: Aged; Aged, 80 and over; Alendronate; Atrial Fibrillation; Atrial Flutter; Bone Density Conservation

2009
Yearly zoledronic acid in postmenopausal osteoporosis.
    The New England journal of medicine, 2007, Aug-16, Volume: 357, Issue:7

    Topics: Administration, Oral; Aged; Alendronate; Atrial Fibrillation; Bone Density Conservation Agents; Diph

2007